In the stroke setting, a possible role for miR-183 lies in negatively regulating PTEN gene expression—it has been shown that following ischemia in mice, the levels of miR-183 were reduced, while transfection with agomiR-183-5p resulted in reduced cerebral ischemic injury and apoptosis [24]. The gene discussed is PTEN; the disease is stroke disorder.